Olivopontocerebellar Atrophy
Symptoms, Doctors, Treatments, Advances & More

Save information for later
Sign Up

Learn About Olivopontocerebellar Atrophy

What is the definition of Olivopontocerebellar Atrophy?
Olivopontocerebellar atrophy (OPCA) is a term used for a progressive condition characterized by the degeneration of nerve cells (neurons) in specific areas of the brain. OPCA can be viewed as a finding of several diseases, and indicates a form of progressive ataxia (abnormal or uncontrolled movements) distinguished by characteristic findings in brain imaging studies and at autopsy (pontine flattening and cerebellar atrophy). It was traditionally divided in hereditary or genetic OPCA and sporadic OPCA. Currently, most of the major forms of hereditary OPCA refer to disorders that overlap with spinocerebellar ataxia (SCA), which is a neurological disorder characterized by ataxia. The sporadic forms are considered now to be a form of multiple system atrophy (MSA). OPCA may also occur in people with prion disorders and inherited metabolic diseases. The main symptom is clumsiness that slowly gets worse. Other symptoms may include problems with balance; speech or swallowing problems; difficulty walking; abnormal eye movements; muscle spasms; and neuropathy. Whether OPCA is inherited (and the inheritance pattern) depends on the underlying cause, if known.
What are the alternative names for Olivopontocerebellar Atrophy?
  • Olivopontocerebellar atrophy
  • OPCA
Who are the top Olivopontocerebellar Atrophy Local Doctors?
Puneet Opal
Elite in Olivopontocerebellar Atrophy
Neurology
Elite in Olivopontocerebellar Atrophy
Neurology
259 E Erie St Ste 1900, Lavin Family Pavilion, 
Chicago, IL 
Experience:
37+ years
Languages Spoken:
English
Offers Telehealth

Puneet Opal is a Neurologist in Chicago, Illinois. Dr. Opal has been practicing medicine for over 37 years and is rated as an Elite provider by MediFind in the treatment of Olivopontocerebellar Atrophy. His top areas of expertise are Spinocerebellar Ataxia Type 1, Giant Axonal Neuropathy, Olivopontocerebellar Atrophy, and Spinocerebellar Ataxia.

Gregory M. Chandler
Advanced in Olivopontocerebellar Atrophy
Radiology | Neuroradiology
Advanced in Olivopontocerebellar Atrophy
Radiology | Neuroradiology

Reading Hospital

420 South 5th Avenue, 
West Reading, PA 
Languages Spoken:
English

. Dr. Chandler is rated as an Advanced provider by MediFind in the treatment of Olivopontocerebellar Atrophy. His top areas of expertise are X-Linked Intellectual Disability, Siderius Type, Aicardi-Goutieres Syndrome, Mohr-Tranebjaerg Syndrome, and PEHO Syndrome.

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Olivopontocerebellar Atrophy
Elite in Olivopontocerebellar Atrophy

Houston Methodist Department Of Neurology-Texas Medical Center

6560 Fannin St Ste 802, 
Houston, TX 
Languages Spoken:
English

Tetsuo Ashizawa is a Neurologist in Houston, Texas. Dr. Ashizawa is rated as an Elite provider by MediFind in the treatment of Olivopontocerebellar Atrophy. His top areas of expertise are Olivopontocerebellar Atrophy, Spinocerebellar Ataxia Type 10, Spinocerebellar Ataxia, Drug Induced Dyskinesia, and Deep Brain Stimulation.

What are the latest Olivopontocerebellar Atrophy Clinical Trials?
A Phase 1 Placebo-Controlled Dose Escalating Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ARO-ATXN2 in Adult Subjects With Spinocerebellar Ataxia Type 2

Summary: Adult participants with spinocerebellar ataxia type 2 (SCA2) who carry ≥33 cytosine, adenine, guanine (CAG) repeats in the ATXN2 gene, and who have met all protocol eligibility criteria will be randomized to receive a single dose of ARO-ATXN2 or placebo and be evaluated for safety, tolerability, pharmacokinetic (PK) and pharmacodynamic (PD) parameters.

Match to trials
Find the right clinical trials for you in under a minute
Get started
Ataxies SpinoCérébelleuses Autosomiques Dominantes et Cognition Sociale - Etude SoCoSca

Summary: Spinocerebellar ataxias are a group of rare neurodegenerative diseases, clinically and genetically highly heterogeneous, with an estimated mean prevalence of 2.7 per 100,000 population. The term spinocerebellar ataxia or SCA is often used for ataxias of genetic origin of autosomal dominant transmission, which are the subject of this study. Recent studies of social cognition in patients with geneti...

Who are the sources who wrote this article ?

Published Date: May 02, 2022
Published By: Genetic and Rare Diseases Informnation Center